Completion of Share Issuance to Molson Coors

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today the completion of the issuance of equity to Molson Coors Beverage Company ("Molson Coors") following the announcement of the strategic partnership between Fever-Tree and Molson Coors on 30 January 2025.

As announced on 30 January 2025, the equity issuance of ordinary shares of £0.0025 each in the Company ("Ordinary Shares") comprises the issuance of 10,856,628 Ordinary Shares (the "Issuance Shares") in the Company at an issue price of 654.2 pence per Ordinary Share (together, the "Issuance").

Application has been made for the Issuance Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective at 8.00 a.m. today, 5 February 2025. The Issuance Shares will be issued credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares.

Following Admission, the total number of Ordinary Shares in issue will be 127,615,093. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares with voting rights will be 127,615,093. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

The resultant new significant shareholdings in the Company, following completion of the Issuance, are set out below.

Additional information